Hoth Therapeutics, Inc. - HOTH

HOTH Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
HOTH	0.8	-17.8	72.4	51.8	87.7	-5.1	-90.9	-98.9	-99.4	-99.4
S&P 500	0.6	-0.2	3.9	7.1	10.6	26.1	35.3	89.4	202.3	34497.7

Compare HOTH with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	HOTH
name	Hoth Therapeutics, Inc.
price	1.29
changes percentage	0.7813
change	0.01
day low	1.28
day high	1.35
year high	3.8
year low	0.58
market cap	8905902
price avg 50	1.03934
price avg 200	0.96806
exchange	NASDAQ
volume	294990
avg volume	9318355
open	1.31
previous close	1.28
eps	-1.27
pe	-1.02
earnings announcement	2025-03-26T20:00:00.000+0000
shares outstanding	6903800
timestamp	2025-01-31 17:58:41

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 64.7%

Overall Quarterly Financial Health: 29.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001711786
revenue	0	0	NaN
gross profit	0	-66834	100.00
gross profit ratio	0	0	NaN
research and development expenses	3480053	4931164	-29.43
operating expenses	7692242	11065554	-30.48
interest income	781	6370	-87.74
interest expense	0	305409	-100.00
ebitda	-153149	0	NaN
ebitdaratio	0	0	NaN
operating income	-7692242	-11065554	30.48
operating income ratio	0	0	NaN
net income	-7845390	-11677362	32.82
net income ratio	0	0	NaN
eps	-2.3	-9.75	76.41

Overall Score of Annual Income Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 0 million in 2023 from 0 million in 2022 representing a change of 100.0%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to -8 million in 2023 from -11 million in 2022 representing a change of 30.48%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to -8 million in 2023 from -12 million in 2022 representing a change of 32.82%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -2.3 in 2023 from -2.3 in 2022 representing a change of 76.41%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 3 million in 2023 from 5 million in 2022 representing a change of -29.43%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 8 million in 2023 from 11 million in 2022 representing a change of -30.48%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001711786
revenue	0	0	NaN
gross profit	0	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	897510	566335	58.48
operating expenses	2132253	1645839	29.55
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	-2132253	-1645839	-29.55
ebitdaratio	0	0	NaN
operating income	-2132253	-1645839	-29.55
operating income ratio	0	0	NaN
net income	-2132053	-1632474	-30.60
net income ratio	0	0	NaN
eps	-0.31	-0.24	-29.17

Overall Score of Quarterly Income Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 58.48%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -29.55%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -29.55%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -30.6%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 2 million in 2024Q3 from 2 million in 2024Q2 representing a change of 29.55%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Earnings per Share (EPS): EPS increased to -0.31 in 2024Q3 from -0.31 in 2024Q2 representing a change of -29.17%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001711786
total assets	9520278	6759381	40.85
total liabilities	704983	1637731	-56.95
total equity	8815295	5121650	72.12
cash and cash equivalents	9292352	6428611	44.55
short term investments	0	209320	-100.00
long term investments	37400	33000	13.33
total current assets	9427713	6726381	40.16
total non current assets	92565	33000	180.50
total current liabilities	678657	1387731	-51.10
total non current liabilities	26326	250000	-89.47
common stock	435	130	234.62
retained earnings	-52944506	-45099116	-17.40
total debt	55165	0	NaN

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 10 million in 2023 from 7 million in 2022 representing a change of 40.85%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 1 million in 2023 from 2 million in 2022 representing a change of -56.95%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 9 million in 2023 from 5 million in 2022 representing a change of 72.12%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 9 million in 2023 from 6 million in 2022 representing a change of 44.55%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 9 million in 2023 from 7 million in 2022 representing a change of 40.16%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1 million in 2023 from 1 million in 2022 representing a change of -51.1%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 234.62%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Retained Earnings: Retained Earnings decreased to -53 million in 2023 from -45 million in 2022 representing a change of -17.4%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001711786
total assets	8307410	10032468	-17.19
total liabilities	813033	691860	17.51
total equity	7494377	9340608	-19.77
cash and cash equivalents	8022763	9654837	-16.90
short term investments	0	0	NaN
long term investments	36819	36819	0.00
total current assets	8236784	9954545	-17.26
total non current assets	70626	77923	-9.36
total current liabilities	810324	680816	19.02
total non current liabilities	2709	11044	-75.47
common stock	690	536	28.73
retained earnings	-58749816	-56617763	-3.77
total debt	33807	41104	-17.75

Overall Score of Quarterly Balance Sheet

0.22 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 8 million in 2024Q3 from 10 million in 2024Q2 representing a change of -17.19%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 17.51%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 7 million in 2024Q3 from 9 million in 2024Q2 representing a change of -19.77%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 8 million in 2024Q3 from 10 million in 2024Q2 representing a change of -16.9%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 8 million in 2024Q3 from 10 million in 2024Q2 representing a change of -17.26%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 19.02%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -59 million in 2024Q3 from -57 million in 2024Q2 representing a change of -3.77%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Common Stock: Common Stock increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of 28.73%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of -17.75%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001711786
net change in cash	2863741	-2109659	235.74
operating cash flow	-8447094	-9297854	9.15
free cash flow	-8447094	-9371854	9.87
capital expenditure	0	-74000	100.00
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	216428	620798	-65.14
accounts payables	-700752	590632	-218.64
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	-74000	100.00
net cash used for investing activites	0	1161695	-100.00
debt repayment	0	0	NaN
common stock issued	11314998	5985103	89.05
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	11317353	6036093	87.49
cash at end of period	9292352	6428611	44.55
accounts receivables	0	0	NaN
cash at beginning of period	6428611	8538270	-24.71

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 3 million in 2023 from -2 million in 2022 representing a change of 235.74%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -8 million in 2023 from -9 million in 2022 representing a change of 9.15%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -8 million in 2023 from -9 million in 2022 representing a change of 9.87%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 1 million in 2022 representing a change of -65.14%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from 0 million in 2022 representing a change of 100.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 1 million in 2023 from 1 million in 2022 representing a change of -218.64%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001711786
operating cash flow	-1634564	-1591725.0	-2.69
free cash flow	-1634564	-1591725	-2.69
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	283332	7054	3916.61
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	-3682300	3682300	-200.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	3682300	-100.00
net change in cash	-1632074	2092209	-178.01
cash at end of period	8022763	9654837	-16.90
cash at beginning of period	9654837	7562628	27.67

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0	0	NaN
net income per share	-2.3	-9.75	76.40
operating cash flow per share	-2.48	-7.76	68.09
free cash flow per share	-2.48	-7.83	68.34
cash per share	2.73	5.54	-50.83
book value per share	2.59	4.28	-39.54
tangible book value per share	2.59	4.28	-39.54
shareholders equity per share	2.59	4.28	-39.54
interest debt per share	0.02	0.26	-93.66
market cap	4909233.6	9340663.8	-47.44
enterprise value	-4327953.4	2912052.8	-248.62
pe ratio	-0.63	-0.8	21.77
price to sales ratio	0	0	NaN
pocfratio	-0.58	-1.0	42.15
pfcf ratio	-0.58	-1.0	41.69
pb ratio	0.56	1.82	-69.46
ptb ratio	0.56	1.82	-69.46
ev to sales	0	0	NaN
enterprise value over ebitda	28.26	0	NaN
ev to operating cash flow	0.51	-0.31	263.59
ev to free cash flow	0.51	-0.31	264.89
earnings yield	-1.6	-1.25	-27.83
free cash flow yield	-1.72	-1.0	-71.49
debt to equity	0.01	0	NaN
debt to assets	0.01	0	NaN
net debt to ebitda	60.32	0	NaN
current ratio	13.89	4.85	186.60
interest coverage	0	-36.23	100.00
income quality	1.08	0.82	31.69
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	-0.01	100.00
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	11.57	30.63	-62.23
roic	-0.87	-2.12	59.00
return on tangible assets	-0.82	-1.73	52.30
graham net net	2.52	4.18	-39.67
working capital	8749056	5338650	63.88
tangible asset value	8815295	5121650	72.12
net current asset value	8722730	5088650	71.42
invested capital	8804221	5338650	64.91
average receivables	0	25000	-100.00
average payables	365290.5	527976.5	-30.81
average inventory	0	-46939014	100.00
days sales outstanding	0	0	NaN
days payables outstanding	0	3795.54	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0.1	-100.00
inventory turnover	0	0	NaN
roe	-0.89	-2.28	60.97
capex per share	0	0.06	-100.00

• Negative

  ROE: Return on Equity (ROE) increased to -0.89 on 2023-12-31 from -2.28 on 2022-12-31, representing a change of 60.97%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 13.89 on 2023-12-31 from 4.85 on 2022-12-31, representing a change of 186.60%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.63 on 2023-12-31 from -0.80 on 2022-12-31, representing a change of 21.77%. Indicating an increase in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
HOTH
calendar year	2024	2024	NaN
revenue per share	0	0	NaN
net income per share	-0.31	-0.24	-30.08
operating cash flow per share	-0.24	-0.23	-2.28
free cash flow per share	-0.24	-0.23	-2.28
cash per share	1.16	1.4	-17.23
book value per share	1.09	1.36	-20.08
tangible book value per share	1.09	1.36	-20.08
shareholders equity per share	1.09	1.36	-20.08
interest debt per share	0.0	0.01	-18.08
market cap	6075347.52	6294593.4	-3.48
enterprise value	-1913608.48	-3319139.6	42.35
pe ratio	-0.71	-0.96	26.10
price to sales ratio	0	0	NaN
pocfratio	-3.72	-3.95	6.01
pfcf ratio	-3.72	-3.95	6.01
pb ratio	0.81	0.67	20.29
ptb ratio	0.81	0.67	20.29
ev to sales	0	0	NaN
enterprise value over ebitda	0.9	2.02	-55.50
ev to operating cash flow	1.17	2.09	-43.86
ev to free cash flow	1.17	2.09	-43.86
earnings yield	-0.35	-0.26	-35.32
free cash flow yield	-0.27	-0.25	-6.40
debt to equity	0.0	0.0	2.51
debt to assets	0.0	0.0	-0.67
net debt to ebitda	3.75	5.84	-35.86
current ratio	10.16	14.62	-30.48
interest coverage	0	0	NaN
income quality	0.77	0.98	-21.37
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	2.75	2.69	1.96
roic	-0.28	-0.17	-61.97
return on tangible assets	-0.26	-0.16	-57.72
graham net net	1.04	1.3	-19.88
working capital	7426460	9273729	-19.92
tangible asset value	7494377	9340608	-19.77
net current asset value	7423751	9262685	-19.85
invested capital	7460267	9314833	-19.91
average receivables	0	0	NaN
average payables	419077.5	347125.5	20.73
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	-0.28	-0.17	-62.78
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to -0.28 on 2024-09-30 Q3 from -0.17 on 2024-06-30 Q2, representing a change of -62.78%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 10.16 on 2024-09-30 Q3 from 14.62 on 2024-06-30 Q2, representing a change of -30.48%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.71 on 2024-09-30 Q3 from -0.96 on 2024-06-30 Q2, representing a change of 26.10%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of 2.51%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 2.71 which is higher than current price 1.29, indicates the company may be undervalued.